Applied dna reschedules investor update call in observance of the national day of mourning in recognition of the passing of former president jimmy carter

Stony brook, ny / accesswire / january 8, 2025 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna" or the "company"), a leader in polymerase chain reaction (pcr)-based technologies, today announced that it has rescheduled its investor update call to thursday, february 13, 2025, to coincide with the release of its first quarter fiscal 2025 financial results. the company originally scheduled an investor update call for january 9, 2025, to update shareholders on its strategic restructuring announced in december 2024 and gmp initiative.
APDN Ratings Summary
APDN Quant Ranking